Birmingham, West Midlands -- (SBWIRE) -- 12/14/2013 -- Value Penny Stocks issues special report on: Quicksilver Resources Inc (NYSE:KWK), Key Energy Services, Inc. (NYSE:KEG), Insys Therapeutics Inc (NASDAQ:INSY), ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC)
Quicksilver Resources Inc (NYSE:KWK) was trading lower by -0.09 points or -3.05% to $2.86.So far, around 1.46 million shares have changed hands in this session. After opening at $2.97, the stock hit as high as $2.99. However, it traded between $1.44 and$3.57 over the last twelve months. Quicksilver Resources Inc. is an independent oil and gas company engaged primarily in the acquisition, exploration, development and production of onshore oil and gas in North America and are based in Fort Worth, Texas.
Has KWK Found The Bottom and Ready To Move Up? Find Out Here
Key Energy Services, Inc. (NYSE:KEG) was at $7.48, showing a -2.73% decrease. Around 952,694.00 shares have been traded, versus an-average trading volume of 2.88M shares. The company is now valued at around $1.14 billion. Key Energy Services, Inc. (Key) is an onshore, rig-based well servicing contractor. The Company provides a range of well services to major oil companies, foreign national oil companies and independent oil and natural gas production companies.
Has KEG Found The Bottom And Ready To Gain Momentum? Find Out Here
Insys Therapeutics Inc (NASDAQ:INSY) moved -16.69 per cent lower at $37.58 and is trading between $33.07 and $39.25 after opening the day at $35.00. Its performance over the last five days remained -20.59%, which stands at -15.34% for a month. Going back further than one month, 1-year performance after recent close was 384.06%. Insys Therapeutics, Inc., is a pharmaceutical company that develops and seeks to commercialize pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care.
Why Should Investors Buy INSY After the Recent Fall? Just Go Here and Find Out
ImmunoCellular Therapeutics Ltd (NYSEMKT:IMUC) shares decline today, losing -5.91 per cent to $1.03. The stock is down around -.62.64% in 2013 and -5.91% for the last 12 months. Around 5.14 million shares changed hands so far in this session compared to an-average trading volume of 2.24M shares. ImmunoCellular Therapeutics, Ltd. is a clinical-stage biotechnology company. The Company is engaged in developing immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors.
Will IMUC Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)